- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Dexia Equities L - Biotechnology
+ Add to WatchlistDEXLBIC:LX
1,905.58 USD 26.76 1.38%As of 00:59:30 ET on 05/16/2013.
Snapshot for Dexia Equities L - Biotechnology (DEXLBIC)
| Year To Date: | +31.11% | 3-Month: | +18.36% | 3-Year: | +25.77% | 52-Week Range: | 1,247.49 - 1,955.90 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +4.19% | 1-Year: | +45.61% | 5-Year: | - | Beta vs BTK: | 0.83 |
Fund Profile & Information for DEXLBIC
Dexia Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
| Inception Date: | 03-03-2010 | Telephone: | 352-254-3431 |
|---|---|---|---|
| Managers: | RUDI VAN DEN EYNDE | ||
| Web Site: | www.dexia-am.com | ||
Fundamentals for DEXLBIC
| NAV | (on 2013-05-16) 1,905.58 |
|---|---|
| Assets (M) | (on 2013-05-16) 361.28 |
| Fund Leveraged | N |
| Minimum Investment | 250,000.00 |
| Minimum Subsequent Investment | - |
Dividends for DEXLBIC
No dividends reported
Fees & Expenses for DEXLBIC
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.55 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 0.66 |
Top Fund Holdings for DEXLBIC
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 450,000 | 22,018,500 | 7.491% |
| Amgen Inc | 196,000 | 20,091,960 | 6.836% |
| Biogen Idec Inc | 84,500 | 16,300,895 | 5.546% |
| Regeneron Pharmaceuticals Inc | 80,000 | 14,112,000 | 4.801% |
| Celgene Corp | 112,000 | 12,981,920 | 4.417% |
| Alexion Pharmaceuticals Inc | 118,000 | 10,872,520 | 3.699% |
| H Lundbeck A/S | 465,000 | 8,578,308 | 2.919% |
| Onyx Pharmaceuticals Inc | 87,000 | 7,730,820 | 2.630% |
| Ablynx NV | 805,000 | 7,039,500 | 2.395% |
| BioMarin Pharmaceutical Inc | 96,000 | 5,976,960 | 2.034% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page